NCT01717053 - Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 17, 2014

Primary Completion Date

August 24, 2017

Study Completion Date

August 31, 2021

Conditions

Prostate Cancer

Interventions

DRUG

Abiraterone acetate

1000 mg orally once a day for 6 months.

DRUG

Androgen deprivation

LHRH analog (at discretion of treating physician) will be administered over 6 months (for example, leuprolide acetate 22.5mg IM or goserelin acetate 10.8mg SC given every 3 months for 2 doses).

RADIATION

Radiation Therapy

Daily (Monday-Friday) for 8 weeks, final dose of 75-80 Gy

DRUG

Prednisone

5 mg tablet once daily for 6 months.

Trial Locations (3)

27704

Durham Regional Hospital, Durham

27710

Duke University Medical Center, Durham

77030

MD Anderson Cancer Center, Houston